Ironwood Pharmaceuticals, Inc. (IRWD)
4.125
-0.16
(-3.85%)
USD |
NASDAQ |
Aug 24, 16:00
4.14
+0.02
(+0.36%)
After-Hours: 20:00
Ironwood Pharmaceuticals Max Drawdown (5Y) : 96.33% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 96.33% |
| June 30, 2026 | 96.33% |
| May 31, 2026 | 96.33% |
| April 30, 2026 | 96.33% |
| March 31, 2026 | 96.33% |
| February 28, 2026 | 96.33% |
| January 31, 2026 | 96.33% |
| December 31, 2025 | 96.33% |
| November 30, 2025 | 96.33% |
| October 31, 2025 | 96.33% |
| September 30, 2025 | 96.33% |
| August 31, 2025 | 96.33% |
| July 31, 2025 | 96.33% |
| June 30, 2025 | 96.33% |
| May 31, 2025 | 96.33% |
| April 30, 2025 | 95.81% |
| March 31, 2025 | 90.87% |
| February 28, 2025 | 89.58% |
| January 31, 2025 | 85.11% |
| December 31, 2024 | 78.38% |
| November 30, 2024 | 78.38% |
| October 31, 2024 | 74.56% |
| September 30, 2024 | 74.56% |
| August 31, 2024 | 73.79% |
| July 31, 2024 | 63.88% |
| Date | Value |
|---|---|
| June 30, 2024 | 63.88% |
| May 31, 2024 | 61.94% |
| April 30, 2024 | 53.39% |
| March 31, 2024 | 53.39% |
| February 29, 2024 | 53.39% |
| January 31, 2024 | 53.39% |
| December 31, 2023 | 53.39% |
| November 30, 2023 | 55.81% |
| October 31, 2023 | 55.81% |
| September 30, 2023 | 55.81% |
| August 31, 2023 | 55.81% |
| July 31, 2023 | 55.81% |
| June 30, 2023 | 55.81% |
| May 31, 2023 | 55.81% |
| April 30, 2023 | 55.81% |
| March 31, 2023 | 55.81% |
| February 28, 2023 | 55.81% |
| January 31, 2023 | 55.81% |
| December 31, 2022 | 55.81% |
| November 30, 2022 | 55.81% |
| October 31, 2022 | 55.81% |
| September 30, 2022 | 55.81% |
| August 31, 2022 | 55.81% |
| July 31, 2022 | 55.81% |
| June 30, 2022 | 55.81% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| AbbVie, Inc. | 21.89% |
| Rigel Pharmaceuticals, Inc. | 86.40% |
| Marker Therapeutics, Inc. | 99.42% |
| Verastem, Inc. | 97.04% |
| Theriva Biologics, Inc. | 99.94% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -25.95 |
| Beta (5Y) | 0.2019 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 79.74% |
| Historical Sharpe Ratio (5Y) | -0.3022 |
| Historical Sortino (5Y) | -0.5304 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.33% |